Navigation Links
Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
Date:9/25/2007

leukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin currently offers an array of Nutraceuticals and OTCeuticals, including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. Interleukin is headquartered in Waltham, MA. For more information about Interleukin and its ongoing programs, please visit http://www.ilgenetics.com.

Certain statements contained herein are "forward-looking" statements including statements regarding our ability to develop diagnostic, personalized nutritional and therapeutic products to prevent or treat diseases of inflammation and other genetic variations, our ability to screen nutritional compounds for their effects on inflammatory responses and other genetic variations, given specific genetic patterns and our ability to make progress in advancing our core technologies. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward- looking statements include, but are not limited to, the risk of market
'/>"/>

SOURCE Interleukin Genetics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
3. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
4. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
5. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
6. Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable Cytogenetics at EHA Meeting
7. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
8. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
9. Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
10. Myriad Genetics Presents Tumor Origin Technology at AACR
11. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Research and ... of the "2015 New Frontiers in ... Technologies, Competitive Landscape" report to their ... Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging ... strategic analysis of major business opportunities emerging ...
(Date:7/2/2015)... julio de 2015 BGI anunció hoy que ... alto rendimiento en Hong Kong ... (CAP). La instalación de BGI en Hong Kong ... próxima generación que recibe la certificación CAP en ... en prácticas de laboratorio clínico. Junto con el exitoso ...
(Date:7/2/2015)... -- ALPINION MEDICAL SYSTEMS Co., Ltd., announced today the ... to enhance user experience and patient care in a ... superb image quality. With advanced imaging technologies, this system ... and shared service applications. Confidence at first ... Series, the E-CUBE 15 EX provides advanced women,s health ...
Breaking Medicine Technology:New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2BGI recibe la acreditación del College of American Pathologists (CAP) 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
... Niiki Pharma Inc. announced today the formation of its ... board, and will be joined by Lee Ellis M.D. and ... guidance to the company for its two first-in-class clinical stage ... mature, the Advisory Board will be expanded. ...
... From today, an innovative non-drug, ... available to all hypertensive patients on NHS prescription. RESPeRATE ... blood pressure. When used for just 15 minutes a ... demonstrated a significant, all-day blood pressure reduction beyond that ...
Cached Medicine Technology:Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists 2Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists 3NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription 2NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription 3NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription 4
(Date:7/4/2015)... ... 2015 , ... Tyler Boden, Project Developer of Sullivan Solar ... the North American Board of Certified Energy Practitioners (NABCEP®), and is now a ... well established national certification organization for renewable energy professionals. Designation as a NABCEP ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US ... with even minimal asbestos exposure. Click here to read the complete story , ... Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice with ...
(Date:7/3/2015)... ... ... Smoothies are all the rage right now and all you need to ... Natural is proud to introduce a new line of all natural products that blend ... minerals! , Aurora is offering a variety of blends and stand-alone items to choose ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The ... he says will reveal biblical truth and expose popular lies regarding proper relationships according ... Don’t Have Sex”, immediately goes into the core of the subject by explaining why ...
(Date:7/2/2015)... , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. ... opening is now the 19th sweetFrog store located in the Lone Star State. The ... fastest growing companies in 2014. , The store, which opened July 1 at Duke’s ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... side effect when combined with a type of medication ... of the saquinavir, one of a class of ... the progression of HIV infection. In the presence of ... 50 percent. ,For the study, nine healthy, HIV-negative ...
... treat everything from heartburn to impotence have prompted one in ... to retain critical information about the drug and possible side ... the Food and Drug Administration set up rules and made ... ads have a considerable effect -- nearly a third of ...
... Novartis' Femara (letrozole), one of a new class of ... tamoxifen in treating breast cancer in women// with advanced ... of drugs called aromatase inhibitors, which work differently to ... ,This new drug, Letrozole shrank tumors better and ...
... of old ladies are the latest mood-enhancing substances to ... those of young men may have the reverse effect. ... due to the human ability to detect the presence ... reports "New Scientist" magazine. ,Denise Chen, at ...
... A new method of treating childhood brain tumours, aimed at ... be trialled at hospitals around the US. Researchers will enrol ... childhood brain tumour – who will be treated with lower ... ,In the US, about 500 children are diagnosed ...
... long-delayed move, the Foods and Drugs Department is beginning ... without qualified pharmacists, an offence under the Indian Drugs ... sources, not only does this common practice jeopardise the ... to deal with high-risk drugs -- it also endangers ...
Cached Medicine News:
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: